Cover Image
市場調查報告書

感染性腹瀉:全球臨床實驗趨勢

Infectious Diarrhea Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 332932
出版日期 內容資訊 英文 68 Pages
訂單完成後即時交付
價格
Back to Top
感染性腹瀉:全球臨床實驗趨勢 Infectious Diarrhea Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月30日 內容資訊: 英文 68 Pages
簡介

本報告提供感染性腹瀉相關之臨床研究最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關研究的進展,有潛力的藥劑比較等資訊。

簡介

  • 感染性腹瀉
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上感染性腹瀉的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上感染性腹瀉的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

感染性腹瀉治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Romark Laboratories, L.C.
    • Merck & Co., Inc.
    • Actelion Ltd
    • QPS, LLC
    • PNMedical
    • LactoPharma
    • HiPP GmbH & Co. Vertrieb KG
    • Glenmark Pharmaceuticals Ltd.
    • BioGaia AB
    • BioFortis, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Christian Medical College, Vellore
    • U.S. Army Medical Research and Materiel Command
    • Baylor College of Medicine
    • Mashhad University of Medical Sciences
    • University of Nottingham

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2680CTIDB

GlobalData's clinical trial report, "Infectious Diarrhea Global Clinical Trials Review, H1, 2015" provides data on the Infectitious Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Infectitious Diarrhea . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Infectitious Diarrhea . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Infectious Diarrhea
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Infectious Diarrhea to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Infectious Diarrhea to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Infectious Diarrhea
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Infectious Diarrhea Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Romark Laboratories, L.C.
      • Clinical Trial Overview of Romark Laboratories, L.C.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Actelion Ltd
      • Clinical Trial Overview of Actelion Ltd
      • QPS, LLC
      • Clinical Trial Overview of QPS, LLC
      • PNMedical
      • Clinical Trial Overview of PNMedical
      • LactoPharma
      • Clinical Trial Overview of LactoPharma
      • HiPP GmbH & Co. Vertrieb KG
      • Clinical Trial Overview of HiPP GmbH & Co. Vertrieb KG
      • Glenmark Pharmaceuticals Ltd.
      • Clinical Trial Overview of Glenmark Pharmaceuticals Ltd.
      • BioGaia AB
      • Clinical Trial Overview of BioGaia AB
      • BioFortis, Inc.
      • Clinical Trial Overview of BioFortis, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Christian Medical College, Vellore
      • Clinical Trial Overview of Christian Medical College, Vellore
      • U.S. Army Medical Research and Materiel Command
      • Clinical Trial Overview of U.S. Army Medical Research and Materiel Command
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • Mashhad University of Medical Sciences
      • Clinical Trial Overview of Mashhad University of Medical Sciences
      • University of Nottingham
      • Clinical Trial Overview of University of Nottingham
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Infectious Diarrhea Therapeutics, Global, Clinical Trials by Region, 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Infectious Diarrhea to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Infectious Diarrhea Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Infectious Diarrhea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Infectious Diarrhea to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Infectious Diarrhea Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Infectious Diarrhea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Infectious Diarrhea Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Infectious Diarrhea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by QPS, LLC, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by PNMedical, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by LactoPharma, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by HiPP GmbH & Co. Vertrieb KG, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Glenmark Pharmaceuticals Ltd., 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by BioGaia AB, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by BioFortis, Inc., 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, Vellore, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nottingham, 2015*

List of Figures

  • Infectious Diarrhea Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Infectious Diarrhea to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Infectious Diarrhea Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Infectious Diarrhea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Infectious Diarrhea to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Infectious Diarrhea Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Infectious Diarrhea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Infectious Diarrhea Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Infectious Diarrhea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Infectious Diarrhea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top